A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/13 (2006.01) A61P 25/18 (2006.01)
Patent
CA 2573091
The present invention provides a method for treating schizophrenia in a patient in need thereof, the method comprising administering to the patient a therapeutically effective amount of memantine, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount an atypical antipsychotic. The method of the present invention embodies both the co- administration of memantine with an atypical antipsychotic, and the use of memantine as an adjunctive treatment to treatment with an atypical antipsychotic.
La présente invention concerne un procédé permettant de traiter la schizophrénie chez un patient le nécessitant, le procédé consiste à administrer au patient une quantité de memantine efficace sur le plan thérapeutique ou d~un sel de celle-ci acceptable sur le plan pharmaceutique et une quantité efficace sur le plan thérapeutique d~antipsychotique atypique. Le procédé de la présente invention regroupe aussi bien la co-administration de la mémantine avec un antipsychotique atypique que l~utilisation de la memantine comme traitement adjuvant au traitement à base d'un antipsychotique atypique.
Gage Allyson
Jonas Jeffery
Forest Laboratories Inc.
Perley-Robertson Hill & Mcdougall Llp
LandOfFree
Memantine as adjunctive treatment to atypical antipsychotics... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Memantine as adjunctive treatment to atypical antipsychotics..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Memantine as adjunctive treatment to atypical antipsychotics... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1959615